Add BrightSurf on Google Email

4TEEN4 Pharmaceuticals GmbH


4TEEN4's first-in-class therapeutic antibody Procizumab restores heart function in life-threatening cardiac depression induced by sepsis

The study data show that Procizumab promptly restored cardiac dysfunction in a preclinical sepsis model by inhibiting the cardiac depressant factor DPP3. The administration of Procizumab improved heart function by increasing cardiac output, stroke volume, and left ventricular shortening fraction.

Source4TEEN4 Pharmaceuticals GmbH·JournalPLOS ONE·DateSep 16, 2020